Literature DB >> 23435692

Rapid detection of antibiotic resistance in Acinetobacter baumannii using quantitative real-time PCR.

Reyes Martín-Peña1, Juan Domínguez-Herrera, Jerónimo Pachón, Michael J McConnell.   

Abstract

OBJECTIVES: The rapid detection of antibiotic resistance in clinical isolates of Acinetobacter baumannii would shorten the period during which patients receive empirical therapy and facilitate the early initiation of directed antibiotic therapy. The objective of this study was to evaluate the ability of a real-time PCR assay to detect antibiotic resistance to four clinically relevant antibiotics from different antibiotic classes in clinical isolates of A. baumannii.
METHODS: The growth of 48 clinical isolates of A. baumannii with a broad range of MICs of imipenem, ciprofloxacin, colistin and amikacin was evaluated using a real-time PCR assay targeting a highly conserved region of the ompA gene. Fold changes in the number of copies of genomic DNA after 6 h of growth were used to determine resistance and the results were compared with those obtained using broth microdilution.
RESULTS: The results obtained using the real-time PCR assay were concordant with broth microdilution for 184 of 192 determinations (95.8%). The global values for specificity (97.5%), sensitivity (92.9%), positive predictive value (95.6%) and negative predictive value (96.0%) indicated that the real-time PCR assay was able to reliably differentiate between resistant and non-resistant strains.
CONCLUSIONS: The use of real-time PCR to monitor bacterial growth in the presence of antibiotics is effective for rapidly identifying antibiotic resistance in A. baumannii.

Entities:  

Keywords:  empirical therapy; multidrug resistance; susceptibility testing

Mesh:

Year:  2013        PMID: 23435692     DOI: 10.1093/jac/dkt057

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  6 in total

1.  Development and Clinical Application of a Recombinase Polymerase Amplification-Lateral Flow Strip Assay for Detection of Carbapenem-Resistant Acinetobacter baumannii.

Authors:  Lei Wang; Dunpo Sun; Li Chen; Ping Zhou; Kun Wang; Fang Wang; Xingqi Lei; Yan Wang; Yingzhi Lu; Guanhong Huang; Xuzhu Gao
Journal:  Front Cell Infect Microbiol       Date:  2022-05-11       Impact factor: 6.073

Review 2.  In vitro antimicrobial susceptibility testing methods: agar dilution to 3D tissue-engineered models.

Authors:  A Schumacher; T Vranken; A Malhotra; J J C Arts; P Habibovic
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2017-09-04       Impact factor: 3.267

3.  Rapid detection and molecular survey of blaVIM, blaIMP and blaNDM genes among clinical isolates of Acinetobacter baumannii using new multiplex real-time PCR and melting curve analysis.

Authors:  Hossein Goudarzi; Elnaz Sadat Mirsamadi; Zohreh Ghalavand; Mojdeh Hakemi Vala; Hamed Mirjalali; Ali Hashemi
Journal:  BMC Microbiol       Date:  2019-06-10       Impact factor: 3.605

Review 4.  Identification and Antibiotic-Susceptibility Profiling of Infectious Bacterial Agents: A Review of Current and Future Trends.

Authors:  Gaetano Maugeri; Iana Lychko; Rita Sobral; Ana C A Roque
Journal:  Biotechnol J       Date:  2018-08-26       Impact factor: 4.677

Review 5.  Outer membrane protein A (OmpA) as a potential therapeutic target for Acinetobacter baumannii infection.

Authors:  Dan Nie; Yue Hu; Zhou Chen; Mingkai Li; Zheng Hou; Xiaoxing Luo; Xinggang Mao; Xiaoyan Xue
Journal:  J Biomed Sci       Date:  2020-01-18       Impact factor: 8.410

6.  Phenotypic and Genotypic Characteristics of Biofilm Formation in Clinical Isolates of Acinetobacter baumannii.

Authors:  Zhaoyinqian Li; Zixuan Ding; Yao Liu; Xinrui Jin; Jingling Xie; Tingting Li; Zhangrui Zeng; Zhibin Wang; Jinbo Liu
Journal:  Infect Drug Resist       Date:  2021-07-07       Impact factor: 4.003

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.